SVALX
Price
$6.30
Change
-$0.06 (-0.94%)
Updated
Nov 12 closing price
VIVAX
Price
$69.35
Change
-$0.54 (-0.77%)
Updated
Nov 12 closing price
Ad is loading...

SVALX vs VIVAX

Header iconSVALX vs VIVAX Comparison
Open Charts SVALX vs VIVAXBanner chart's image
Federated Hermes Strategic Value Div R6
Price$6.30
Change-$0.06 (-0.94%)
VolumeN/A
CapitalizationN/A
Vanguard Value Index I
Price$69.35
Change-$0.54 (-0.77%)
VolumeN/A
CapitalizationN/A
SVALX vs VIVAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
SVALX vs. VIVAX commentary
Nov 13, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SVALX is a Sell and VIVAX is a StrongSell.

FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 184B vs. SVALX (8.36B). SVALX pays higher dividends than VIVAX: SVALX (4.23) vs VIVAX (2.25). SVALX was incepted earlier than VIVAX: SVALX (8 years) vs VIVAX (32 years). SVALX is a more actively managed with annual turnover of: 35.00 vs. VIVAX (10.00). SVALX has a lower initial minimum investment than VIVAX: SVALX (0) vs VIVAX (3000). SVALX (29.69) and VIVAX (29.30) have marching annual gain over last year. VIVAX return over 5 years is better than : 53.44 vs. SVALX (31.70).
SVALXVIVAXSVALX / VIVAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence8 years32 years-
Gain YTD18.85518.99399%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets8.36B184B5%
Annual Yield % from dividends4.232.25188%
Returns for 1 year29.6929.30101%
Returns for 3 years23.9022.52106%
Returns for 5 years31.7053.4459%
Returns for 10 yearsN/A113.82-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NXPL1.150.05
+4.55%
NextPlat Corp
TRUP53.751.34
+2.56%
Trupanion
CRNT2.550.02
+0.79%
Ceragon Networks Ltd
FICO2348.10-1.90
-0.08%
Fair Isaac Corp
DNLI29.90-1.68
-5.32%
Denali Therapeutics